Try our beta test site
66 studies found for:    "Primary sclerosing cholangitis"
Show Display Options
Rank Status Study
21 Recruiting Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis
Condition: Primary Sclerosing Cholangitis
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674
22 Completed Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Biological: Simtuzumab;   Biological: Placebo
23 Active, not recruiting Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Interventions: Drug: OCA;   Drug: Placebo
24 Completed Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: LUM001
25 Recruiting Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures
Condition: Primary Sclerosing Cholangitis
Intervention: Device: probe based confocal laser endomicroscopy
26 Recruiting Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Condition: Sclerosing Cholangitis
Intervention: Biological: Fecal Microbiota Transplantation
27 Recruiting Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Oral Vancomycin
28 Completed
Has Results
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Vancomycin
29 Recruiting A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Drug: Vancomycin
30 Completed Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis;   Cholangiocarcinoma
Intervention: Diagnostic Test: MR/MRCP
31 Unknown  NPD Measurements in PSC Patients
Condition: Primary Sclerosing Cholangitis
Intervention:
32 Withdrawn Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Interventions: Drug: Vedolizumab;   Drug: Placebo
33 Recruiting Genomics of Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Genetic: Genetic Analysis
34 Completed Trial of High-dose Urso in Primary Sclerosing Cholangitis
Condition: Sclerosing Cholangitis
Intervention: Drug: Ursodeoxycholic Acid
35 Completed A Pilot Study of Xifaxan to Treat Patients With PSC
Condition: Primary Sclerosing Cholangitis (PSC)
Intervention: Drug: Xifaxan
36 Completed Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)
Condition: Sclerosing Cholangitis
Intervention:
37 Terminated
Has Results
Fenofibrate for PSC
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: fenofibrate
38 Recruiting Vancomycin Treatment in Recurrent PSC in Liver Transplant Patients
Conditions: Primary Sclerosing Cholangitis;   Post- Orthotopic Liver Transplantation
Intervention: Drug: Vancomycin
39 Recruiting Secondary Sclerosing Cholangitis in Critically Ill Patients
Condition: Secondary Sclerosing Cholangitis
Intervention:
40 Completed Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis;   Trisomy 7;   Cholangiocarcinoma;   Chemoprevention
Intervention: Drug: Erlotinib (Tarceva)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.